Net Loss Per Share

6 Months Ended

Jun. 30, 2025

The Company’s potential dilutive securities have been excluded from the computation of diluted net loss per share as the effect would be anti-dilutive. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at period end, from the computation of diluted net loss per share attributable to common stockholders for the period indicated because including them would have had an anti-dilutive effect:


	June 30,
	2025	2024
Common stock options granted and outstanding	3,888,145	3,005,809
Warrants to purchase common stock	164,252	164,676
Restricted stock units granted and outstanding	29,740	—
ESPP shares to be purchased	4,791	—
Total	4,086,928	3,170,485